Risk of endometrial cancer in relationship to cigarette smoking: results from the EPIC study.
Al-Zoughool M, Dossus L, Kaaks R, Clavel-Chapelon F, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Gauthier E, Linseisen J, Chang-Claude J, Boeing H, Schulz M, Trichopoulou A, Chryssa T, Trichopoulos D, Berrino F, Palli D, Mattiello A, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Boshuizen HC, Peeters PH, Gram IT, Braaten T, Lund E, Chirlaque MD, Ardanaz E, Agudo A, Larrañaga N, Quirós JR, Berglund G, Manjer J, Lundin E, Hallmans G, Khaw KT, Bingham S, Allen N, Key T, Jenab M, Cust AE, Rinaldi S, Riboli E.
Int J Cancer 2007; 121: 2741-7.
Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition.
Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Rinaldi S, Egevad L, Rohrmann S, Linseisen J, Pischon T, Boeing H, Johnsen NF, Tjønneland A, Grønbaek H, Overvad K, Kiemeney L, Bueno-de-Mesquita HB, Bingham S, Khaw KT, Tumino R, Berrino F, Mattiello A, Sacerdote C, Palli D, Quirós JR, Ardanaz E, Navarro C, Larrañaga N, Gonzalez C, Sanchez MJ, Trichopoulou A, Travezea C, Trichopoulos D, Jenab M, Ferrari P, Riboli E, Kaaks R.
Cancer Epidemiol Biomarkers Prev 2007; 16: 1121-7.
The role of asbestos fiber dimensions in the prevention of mesothelioma.
Tomatis L, Cantoni S, Carnevale F, Merler E, Mollo F, Ricci P, Silvestri S, Vineis P, Terracini B.
Int J Occup Environ Health 2007; 13: 64-9.
CDKN2A germline mutations in individuals with cutaneous malignant melanoma.
Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M; GEM Study Group.
J Invest Dermatol 2007; 127: 1234-43.
Short- and long-term mortality with localized prostate cancer.
Merglen A, Schmidlin F, Fioretta G, Verkooijen HM, Rapiti E, Zanetti R, Miralbell R, Bouchardy C.
Arch Intern Med 2007; 167: 1944-50.
Ambient UV, personal sun exposure and risk of multiple primary melanomas.
Kricker A, Armstrong BK, Goumas C, Litchfield M, Begg CB, Hummer AJ, Marrett LD, Theis B, Millikan RC, Thomas N, Culver HA, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Zanetti R, Berwick M; for the GEM Study Group.
Cancer Causes Control 2007; 18: 295-304.
Levodopa and the risk of melanoma.
Zanetti R, Rosso S.
Lancet 2007; 369: 257-8.
Occupation and skin cancer: the results of the HELIOS-I multicenter case-control study.
Suárez B, López-Abente G, Martínez C, Navarro C, Tormo MJ, Rosso S, Schraub S, Gafà L, Sancho-Garnier H, Wechsler J, Zanetti R.
BMC Public Health 2007; 7: 180.
Is 2,3,5-pyrroletricarboxylic acid in hair a better risk indicator for melanoma than traditional epidemiologic measures for skin phenotype?
Rosso S, Zanetti R, Sánchez MJ, Nieto A, Miranda A, Mercier M, Loria D, Østerlind A, Greinert R, Chirlaque MD, Fabbrocini G, Barbera C, Sancho-Garnier H, Lauria C, Balzi D, Zoccola M; Helios Working Group.
Am J Epidemiol 2007; 165: 1170-7.
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.
Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, Santaquilani M; EUROCARE Working group.
Lancet Oncol 2007; 8: 773-83. Erratum in: Lancet Oncol 2007; 8: 868.